Interleukin 2 (IL-2) is critical for T cell development and homeostasis, being a key regulator of adaptive immune responses in autoimmunity,
hypersensitivity reactions and
cancer. Therefore, its abundance in serum and peripheral tissues needs tight control. Here, we described a new mechanism contributing to the immunobiology of
IL-2. We demonstrated, both in biochemical and cell-based assays, that
IL-2 is subject to proteolytic processing by neutrophil
matrix metalloproteinase-9 (MMP-9).
IL-2 fragments produced after cleavage by MMP-9 remained linked by a
disulfide bond and displayed a reduced affinity for all
IL-2 receptor subunits and a distinct pattern and timing of signal transduction. Stimulation of IL-2-dependent cells, including murine CTLL-2 and primary human regulatory T cells, with cleaved
IL-2 resulted in significantly decreased proliferation. The concerted action of neutrophil
proteases destroyed
IL-2. Our data suggest that in neutrophil-rich inflammatory conditions in vivo, neutrophil MMP-9 may reduce the abundance of signaling-competent
IL-2 and generate a fragment that competes with
IL-2 for receptor binding, whereas the combined activity of granulocyte
proteases has the potential to degrade and thus eliminate bioavailable
IL-2.